サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1513632

哺乳類細胞バンキングの世界市場：産業分析、規模、シェア、成長、動向、予測、2024～2033年

Mammalian Cell Banking Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日: | 発行: Persistence Market Research | ページ情報: 英文 251 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
哺乳類細胞バンキングの世界市場：産業分析、規模、シェア、成長、動向、予測、2024～2033年
出版日: 2024年07月05日
発行: Persistence Market Research
ページ情報: 英文 251 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートは、世界の哺乳類細胞バンキング市場に関する包括的なレポートを発表しました。市場促進要因・動向・機会・課題を含む重要な市場ダイナミクスを徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主な洞察

  • 哺乳類細胞バンキングの市場規模（2024年）：4億9,650万米ドル
  • 予測市場金額（2033年）：16億米ドル
  • 世界市場成長率（CAGR 2024～2033年）：13.9%

哺乳類細胞バンキング市場 - レポート範囲：

哺乳類細胞バンキングは、バイオ医薬品およびバイオテクノロジー産業において重要な役割を担っており、医薬品開発、ワクチン製造、再生医療など様々な用途の細胞株の安定した保管場所を提供しています。同市場は製薬会社、学術機関、研究所、開発業務受託機関（CRO）にサービスを提供しており、細胞株の特性解析、保管、流通など幅広いサービスを提供しています。

市場成長の促進要因：

世界の哺乳類細胞バンキング市場は、バイオ医薬品に対する需要の増加、細胞ベースの治療法に対する投資の増加、細胞株の安定性と生産性を高めるバイオテクノロジーの進歩など、いくつかの主要な要因によって牽引されています。慢性疾患の有病率の増加や生物製剤の効率的生産の必要性が、市場拡大をさらに後押ししています。さらに、凍結保存技術や品質管理対策における技術革新は、保存された細胞株の完全性と生存性を確保することで市場拡大に貢献しています。

市場抑制要因：

有望な成長展開にもかかわらず、哺乳類細胞バンキング市場は、規制遵守、細胞株調達における倫理的配慮、長期保存期間中の細胞株の信頼性と純度の維持の複雑さに関する課題に直面しています。細胞バンキング実務を管理する厳しい規制や、汚染を防ぐための継続的なモニタリングの必要性は、市場プレーヤーに運用上の課題を課し、拡張性やコスト効率に影響を与えます。

市場機会：

哺乳類細胞バンキング市場は、個別化医療、細胞治療、幹細胞研究における新たな応用により、大きな成長機会をもたらしています。細胞バンキング施設に自動化とロボット工学を統合することで、業務効率が向上し、人的ミスが減少するため、細胞株の管理と保管が最適化されます。さらに、バイオ製薬企業、学術機関、CRO間の戦略的提携は、知識交換を促進し、細胞バンキング技術の革新を加速します。

本レポートで扱う主な質問

  • 世界の哺乳類細胞バンキング市場の成長を促す主な要因は何か？
  • 哺乳類細胞バンキングサービスの需要を牽引している用途と治療分野は？
  • 技術進歩は哺乳類細胞バンキング市場の競合情勢をどのように変えているのか？
  • 哺乳類細胞バンキング市場に貢献している主要プレイヤーは誰で、市場のリーダーシップを維持するためにどのような戦略をとっているのか？
  • 世界の哺乳類細胞バンキング市場の新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類
  • 市場の定義/範囲/制限
  • 包含と除外

第3章 主要市場動向

  • 市場に影響を与える主な動向
  • 開発/イノベーションの動向

第4章 主要成功要因

  • パイプライン評価
  • バリューチェーン分析
  • 主要メーカーによる主要プロモーション戦略
  • 規制状況
  • PESTLE分析
  • ポーターの分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学

第6章 COVID-19危機 - 影響評価

  • COVID-19と影響分析
    • 細胞別
    • 用途別
    • エンドユーザー別
    • 地域別
  • 2024年の市場シナリオ

第7章 世界の哺乳類細胞バンキング市場の需要金額または規模（100万米ドル）分析

  • 過去の市場金額（100万米ドル）分析、2019～2023年
  • 現在および将来の市場金額（100万米ドル）予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的ドル機会分析

第8章 世界の哺乳類細胞バンキングの市場分析：細胞別

  • イントロダクション/主な調査結果
  • 過去の市場規模（100万米ドル）分析、細胞別、2019～2023年
  • 現在および将来の市場規模（100万米ドル）分析と予測、細胞別、2024～2033年
    • CHO
    • BHK
    • NS0
    • YB2/0・P2/0
    • HEK293・誘導体
    • HELA
  • 市場魅力分析：細胞別

第9章 世界の哺乳類細胞バンキングの市場分析：技術別

  • イントロダクション/主な調査結果
  • 過去の市場規模（100万米ドル）分析、技術別、2019～2023年
  • 現在および将来の市場規模（100万米ドル）分析と予測、技術別、2024～2033年
    • TEP
    • IEP
    • SEP
  • 市場魅力分析：技術別

第10章 世界の哺乳類細胞バンキングの市場分析：用途別

  • イントロダクション/主な調査結果
  • 過去の市場規模（100万米ドル）分析、用途別、2019～2023年
  • 現在および将来の市場規模（100万米ドル）分析と予測、用途別、2024～2033年
    • MCB
    • WCB
    • EoP
    • R&D CB
  • 市場魅力分析：用途別

第11章 世界の哺乳類細胞バンキングの市場分析：エンドユーザー別

  • イントロダクション/主な調査結果
  • 過去の市場規模（100万米ドル）分析、エンドユーザー別、2019～2023年
  • 現在および将来の市場規模（100万米ドル）分析と予測、エンドユーザー別、2024～2033年
    • 学術調査機関
    • バイオ医薬品企業
    • CRO
  • 市場魅力分析：エンドユーザー別

第12章 世界の哺乳類細胞バンキングの市場分析：地域別

  • イントロダクション/主な調査結果
  • 過去の市場規模（100万米ドル）分析、地域別、2019～2023年
  • 現在および将来の市場規模（100万米ドル）分析と予測、地域別、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 市場魅力分析：地域別

第13章 北米の哺乳類細胞バンキングの市場分析

第14章 ラテンアメリカの哺乳類細胞バンキングの市場分析

第15章 欧州の哺乳類細胞バンキングの市場分析

第16章 南アジアの哺乳類細胞バンキングの市場分析

第17章 東アジアの哺乳類細胞バンキングの市場分析

第18章 オセアニアの哺乳類細胞バンキングの市場分析

第19章 中東・アフリカの哺乳類細胞バンキングの市場分析

第20章 市場構造分析

  • 市場分析、企業階層別
  • 主要企業の市場シェア分析（%）
  • 市場プレゼンス分析

第21章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Eurofins DiscoverX Corporation
    • Merck KGaA
    • Sartorius Stedim BioOutsource Limited.
    • Charles River Laboratories
    • Altogen Labs
    • Abzena Ltd
    • Northway Biotechpharma
    • Lonza Group Ltd
    • VIRUSURE
    • Selexis SA
    • Sigma-Aldrich
    • Takara Bio Inc

第22章 使用される仮定と頭字語

第23章 調査手法

目次
Product Code: PMRREP31663

Persistence Market Research has recently released a comprehensive report on the worldwide market for mammalian cell banking. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Mammalian Cell Banking Market Size (2024E): USD 496.5 Million
  • Projected Market Value (2033F): USD 1600 Million
  • Global Market Growth Rate (CAGR 2024 to 2033): 13.9%

Mammalian Cell Banking Market - Report Scope:

Mammalian cell banking plays a crucial role in biopharmaceutical and biotechnology industries, providing a stable repository of cell lines for various applications, including drug development, vaccine production, and regenerative medicine. The market serves pharmaceutical companies, academic institutions, research laboratories, and contract research organizations (CROs), offering a range of services such as cell line characterization, storage, and distribution.

Market Growth Drivers:

The global mammalian cell banking market is driven by several key factors, including the increasing demand for biopharmaceuticals, rising investments in cell-based therapies, and advancements in biotechnology that enhance cell line stability and productivity. The growing prevalence of chronic diseases and the need for efficient production of biologics further propel market expansion. Moreover, technological innovations in cryopreservation techniques and quality control measures contribute to market growth by ensuring the integrity and viability of stored cell lines.

Market Restraints:

Despite promising growth prospects, the mammalian cell banking market faces challenges related to regulatory compliance, ethical considerations in cell line sourcing, and the complexity of maintaining cell line authenticity and purity over extended storage periods. Stringent regulations governing cell banking practices and the need for continuous monitoring to prevent contamination impose operational challenges on market players, affecting scalability and cost-efficiency.

Market Opportunities:

The mammalian cell banking market presents significant growth opportunities driven by emerging applications in personalized medicine, cell therapy, and stem cell research. The integration of automation and robotics in cell banking facilities enhances operational efficiency and reduces human error, thereby optimizing cell line management and storage. Furthermore, strategic collaborations between biopharmaceutical companies, academic institutions, and CROs facilitate knowledge exchange and accelerate innovation in cell banking technologies.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the mammalian cell banking market globally?
  • Which applications and therapeutic areas are driving demand for mammalian cell banking services?
  • How are technological advancements reshaping the competitive landscape of the mammalian cell banking market?
  • Who are the key players contributing to the mammalian cell banking market, and what strategies are they employing to maintain market leadership?
  • What are the emerging trends and future prospects in the global mammalian cell banking market?

Competitive Intelligence and Business Strategy:

Leading players in the global mammalian cell banking market, including Merck KGaA, Altogen Labs, and VIRUSURE, focus on innovation, expansion of service portfolios, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced cell banking solutions, including automated cryopreservation systems, cell line authentication technologies, and personalized medicine applications. Collaborations with regulatory agencies and industry stakeholders promote compliance with international quality standards and facilitate market access.

Key Companies Profiled:

  • Eurofins DiscoverX Corporation
  • Merck KGaA
  • Sartorius Stedim BioOutsource Limited.
  • Charles River Laboratories
  • Altogen Labs
  • Abzena Ltd
  • Northway Biotechpharma
  • Lonza Group Ltd
  • VIRUSURE
  • Selexis SA
  • Takara Bio Inc

Key Segments Covered in Manufacturing of Industry Research

Cell Type:

  • CHO
  • BHK
  • NS0
  • YB2/0 & P2/0
  • HEK293 & Derivatives
  • HELA

Technology:

  • TEP
  • IEP
  • SEP

Application:

  • MCB
  • WCB
  • EoP
  • R&D CB

End User:

  • Academic & Research Institute
  • Biopharmaceutical Companies
  • CROs

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Development/Innovation Trends

4. Key Success Factors

  • 4.1. Pipeline Assessment
  • 4.2. Value chain Analysis
  • 4.3. Key Promotional Strategies, By Key Manufacturers
  • 4.4. Regulatory Landscape
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Global Cell Banking Outsourcing Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Key Player's Historic Growth
    • 5.2.2. Market Consolidation Activities
    • 5.2.3. Increasing Geriatric Population
    • 5.2.4. Rising Cases of Cancer
    • 5.2.5. Growing Preference of Mammalian Cell Banking
    • 5.2.6. Increased R&D investments by Government
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Cell
    • 6.1.2. By Technology
    • 6.1.3. By Application
    • 6.1.4. By End User
    • 6.1.5. By Region
  • 6.2. 2024 Market Scenario

7. Global Mammalian Cell Banking Market Demand Value or Size in (US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Cell

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Cell, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cell, 2024-2033
    • 8.3.1. CHO
    • 8.3.2. BHK
    • 8.3.3. NS0
    • 8.3.4. YB2/0 & P2/0
    • 8.3.5. HEK293 & Derivatives
    • 8.3.6. HELA
  • 8.4. Market Attractiveness Analysis By Cell

9. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Technology

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) By Technology, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2024-2033
    • 9.3.1. TEP
    • 9.3.2. IEP
    • 9.3.3. SEP
  • 9.4. Market Attractiveness Analysis By Technology

10. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2033
    • 10.3.1. MCB
    • 10.3.2. WCB
    • 10.3.3. EoP
    • 10.3.4. R&D CB
  • 10.4. Market Attractiveness Analysis By Application

11. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
    • 11.3.1. Academic & Research Institute
    • 11.3.2. Biopharmaceutical Companies
    • 11.3.3. CROs
  • 11.4. Market Attractiveness Analysis By End User

12. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2023
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Cell
    • 13.3.3. By Technology
    • 13.3.4. By Application
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Cell
    • 13.4.3. By Technology
    • 13.4.4. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Mammalian Cell Banking Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Cell
        • 13.8.1.2.2. By Technology
        • 13.8.1.2.3. By Application
        • 13.8.1.2.4. By End User
    • 13.8.2. Canada Mammalian Cell Banking Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Cell
        • 13.8.2.2.2. By Technology
        • 13.8.2.2.3. By Application
        • 13.8.2.2.4. By End User

14. Latin America Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Cell
    • 14.3.3. By Technology
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Cell
    • 14.4.3. By Technology
    • 14.4.4. By Application
    • 14.4.5. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico Mammalian Cell Banking Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Cell
        • 14.8.1.2.2. By Technology
        • 14.8.1.2.3. By Application
        • 14.8.1.2.4. By End User
    • 14.8.2. Brazil Mammalian Cell Banking Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Cell
        • 14.8.2.2.2. By Technology
        • 14.8.2.2.3. By Application
        • 14.8.2.2.4. By End User
    • 14.8.3. Argentina Mammalian Cell Banking Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Cell
        • 14.8.3.2.2. By Technology
        • 14.8.3.2.3. By Application
        • 14.8.3.2.4. By End User

15. Europe Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Italy
      • 15.3.1.2. Germany
      • 15.3.1.3. U.K
      • 15.3.1.4. France
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Nordic Countries
      • 15.3.1.8. Russia
      • 15.3.1.9. Rest of Europe
    • 15.3.2. By Cell
    • 15.3.3. By Technology
    • 15.3.4. By Application
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Cell
    • 15.4.3. By Technology
    • 15.4.4. By Application
    • 15.4.5. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Italy Mammalian Cell Banking Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Cell
        • 15.8.1.2.2. By Technology
        • 15.8.1.2.3. By Application
        • 15.8.1.2.4. By End User
    • 15.8.2. Germany Mammalian Cell Banking Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Cell
        • 15.8.2.2.2. By Technology
        • 15.8.2.2.3. By Application
        • 15.8.2.2.4. By End User
    • 15.8.3. U.K. Mammalian Cell Banking Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Cell
        • 15.8.3.2.2. By Technology
        • 15.8.3.2.3. By Application
        • 15.8.3.2.4. By End User
    • 15.8.4. France Mammalian Cell Banking Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Cell
        • 15.8.4.2.2. By Technology
        • 15.8.4.2.3. By Application
        • 15.8.4.2.4. By End User
    • 15.8.5. Spain Mammalian Cell Banking Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Cell
        • 15.8.5.2.2. By Technology
        • 15.8.5.2.3. By Application
        • 15.8.5.2.4. By End User
    • 15.8.6. BENELUX Mammalian Cell Banking Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Cell
        • 15.8.6.2.2. By Technology
        • 15.8.6.2.3. By Application
        • 15.8.6.2.4. By End User
    • 15.8.7. Nordic Countries Mammalian Cell Banking Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Cell
        • 15.8.7.2.2. By Technology
        • 15.8.7.2.3. By Application
        • 15.8.7.2.4. By End User
    • 15.8.8. Russia Mammalian Cell Banking Market Analysis
      • 15.8.8.1. Introduction
      • 15.8.8.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.8.2.1. By Cell
        • 15.8.8.2.2. By Technology
        • 15.8.8.2.3. By Application
        • 15.8.8.2.4. By End User

16. South Asia Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Cell
    • 16.3.3. By Technology
    • 16.3.4. By Application
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Cell
    • 16.4.3. By Technology
    • 16.4.4. By Application
    • 16.4.5. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Mammalian Cell Banking Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Cell
        • 16.8.1.2.2. By Technology
        • 16.8.1.2.3. By Application
        • 16.8.1.2.4. By End User
    • 16.8.2. Indonesia Mammalian Cell Banking Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Cell
        • 16.8.2.2.2. By Technology
        • 16.8.2.2.3. By Application
        • 16.8.2.2.4. By End User
    • 16.8.3. Malaysia Mammalian Cell Banking Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Cell
        • 16.8.3.2.2. By Technology
        • 16.8.3.2.3. By Application
        • 16.8.3.2.4. By End User
    • 16.8.4. Thailand Mammalian Cell Banking Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Cell
        • 16.8.4.2.2. By Technology
        • 16.8.4.2.3. By Application
        • 16.8.4.2.4. By End User

17. East Asia Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Cell
    • 17.3.3. By Technology
    • 17.3.4. By Application
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Cell
    • 17.4.3. By Technology
    • 17.4.4. By Application
    • 17.4.5. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. China Mammalian Cell Banking Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Cell
        • 17.8.1.2.2. By Technology
        • 17.8.1.2.3. By Application
        • 17.8.1.2.4. By End User
    • 17.8.2. Japan Mammalian Cell Banking Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Cell
        • 17.8.2.2.2. By Technology
        • 17.8.2.2.3. By Application
        • 17.8.2.2.4. By End User
    • 17.8.3. South Korea Mammalian Cell Banking Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Cell
        • 17.8.3.2.2. By Technology
        • 17.8.3.2.3. By Application
        • 17.8.3.2.4. By End User

18. Oceania Mammalian Cell Banking Market 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Cell
    • 18.3.3. By Technology
    • 18.3.4. By Application
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Cell
    • 18.4.3. By Technology
    • 18.4.4. By Application
    • 18.4.5. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Mammalian Cell Banking Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Cell
        • 18.8.1.2.2. By Technology
        • 18.8.1.2.3. By Application
        • 18.8.1.2.4. By End User
    • 18.8.2. New Zealand Mammalian Cell Banking Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Cell
        • 18.8.2.2.2. By Technology
        • 18.8.2.2.3. By Application
        • 18.8.2.2.4. By End User

19. Middle East and Africa (MEA) Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkey
      • 19.3.1.3. South Africa
      • 19.3.1.4. North Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Cell
    • 19.3.3. By Technology
    • 19.3.4. By Application
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Cell
    • 19.4.3. By Technology
    • 19.4.4. By Application
    • 19.4.5. By End User
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Mammalian Cell Banking Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Cell
        • 19.8.1.2.2. By Technology
        • 19.8.1.2.3. By Application
        • 19.8.1.2.4. By End User
    • 19.8.2. Turkey Mammalian Cell Banking Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Cell
        • 19.8.2.2.2. By Technology
        • 19.8.2.2.3. By Application
        • 19.8.2.2.4. By End User
    • 19.8.3. South Africa Mammalian Cell Banking Market Analysis
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Cell
        • 19.8.3.2.2. By Technology
        • 19.8.3.2.3. By Application
        • 19.8.3.2.4. By End User
    • 19.8.4. North Africa Mammalian Cell Banking Market Analysis
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Cell
        • 19.8.4.2.2. By Technology
        • 19.8.4.2.3. By Application
        • 19.8.4.2.4. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players (%)
  • 20.3. Market Presence Analysis
    • 20.3.1. By Regional Footprint of Players
    • 20.3.2. Cell Footprint of Players
    • 20.3.3. Channel Footprint of Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Eurofins DiscoverX Corporation
      • 21.3.1.1. Overview
      • 21.3.1.2. Product & Services Portfolio
      • 21.3.1.3. Key Financials
      • 21.3.1.4. SWOT Analysis
      • 21.3.1.5. Key Developments
      • 21.3.1.6. Sales Footprint
      • 21.3.1.7. Strategy Overview
        • 21.3.1.7.1. Marketing Strategy
        • 21.3.1.7.2. Product Strategy
        • 21.3.1.7.3. Channel Strategy
    • 21.3.2. Merck KGaA
      • 21.3.2.1. Overview
      • 21.3.2.2. Product & Services Portfolio
      • 21.3.2.3. Key Financials
      • 21.3.2.4. SWOT Analysis
      • 21.3.2.5. Key Developments
      • 21.3.2.6. Sales Footprint
      • 21.3.2.7. Strategy Overview
        • 21.3.2.7.1. Marketing Strategy
        • 21.3.2.7.2. Product Strategy
        • 21.3.2.7.3. Channel Strategy
    • 21.3.3. Sartorius Stedim BioOutsource Limited.
      • 21.3.3.1. Overview
      • 21.3.3.2. Product & Services Portfolio
      • 21.3.3.3. Key Financials
      • 21.3.3.4. SWOT Analysis
      • 21.3.3.5. Key Developments
      • 21.3.3.6. Sales Footprint
      • 21.3.3.7. Strategy Overview
        • 21.3.3.7.1. Marketing Strategy
        • 21.3.3.7.2. Product Strategy
        • 21.3.3.7.3. Channel Strategy
    • 21.3.4. Charles River Laboratories
      • 21.3.4.1. Overview
      • 21.3.4.2. Product & Services Portfolio
      • 21.3.4.3. Key Financials
      • 21.3.4.4. SWOT Analysis
      • 21.3.4.5. Key Developments
      • 21.3.4.6. Sales Footprint
      • 21.3.4.7. Strategy Overview
        • 21.3.4.7.1. Marketing Strategy
        • 21.3.4.7.2. Product Strategy
        • 21.3.4.7.3. Channel Strategy
    • 21.3.5. Altogen Labs
      • 21.3.5.1. Overview
      • 21.3.5.2. Product & Services Portfolio
      • 21.3.5.3. Key Financials
      • 21.3.5.4. SWOT Analysis
      • 21.3.5.5. Key Developments
      • 21.3.5.6. Sales Footprint
      • 21.3.5.7. Strategy Overview
        • 21.3.5.7.1. Marketing Strategy
        • 21.3.5.7.2. Product Strategy
        • 21.3.5.7.3. Channel Strategy
    • 21.3.6. Abzena Ltd
      • 21.3.6.1. Overview
      • 21.3.6.2. Product & Services Portfolio
      • 21.3.6.3. Key Financials
      • 21.3.6.4. SWOT Analysis
      • 21.3.6.5. Key Developments
      • 21.3.6.6. Sales Footprint
      • 21.3.6.7. Strategy Overview
        • 21.3.6.7.1. Marketing Strategy
        • 21.3.6.7.2. Product Strategy
        • 21.3.6.7.3. Channel Strategy
    • 21.3.7. Northway Biotechpharma
      • 21.3.7.1. Overview
      • 21.3.7.2. Product & Services Portfolio
      • 21.3.7.3. Key Financials
      • 21.3.7.4. SWOT Analysis
      • 21.3.7.5. Key Developments
      • 21.3.7.6. Sales Footprint
      • 21.3.7.7. Strategy Overview
        • 21.3.7.7.1. Marketing Strategy
        • 21.3.7.7.2. Product Strategy
        • 21.3.7.7.3. Channel Strategy
    • 21.3.8. Lonza Group Ltd
      • 21.3.8.1. Overview
      • 21.3.8.2. Product & Services Portfolio
      • 21.3.8.3. Key Financials
      • 21.3.8.4. SWOT Analysis
      • 21.3.8.5. Key Developments
      • 21.3.8.6. Sales Footprint
      • 21.3.8.7. Strategy Overview
        • 21.3.8.7.1. Marketing Strategy
        • 21.3.8.7.2. Product Strategy
        • 21.3.8.7.3. Channel Strategy
    • 21.3.9. VIRUSURE
      • 21.3.9.1. Overview
      • 21.3.9.2. Product & Services Portfolio
      • 21.3.9.3. Key Financials
      • 21.3.9.4. SWOT Analysis
      • 21.3.9.5. Key Developments
      • 21.3.9.6. Sales Footprint
      • 21.3.9.7. Strategy Overview
        • 21.3.9.7.1. Marketing Strategy
        • 21.3.9.7.2. Product Strategy
        • 21.3.9.7.3. Channel Strategy
    • 21.3.10. Selexis SA
      • 21.3.10.1. Overview
      • 21.3.10.2. Product & Services Portfolio
      • 21.3.10.3. Key Financials
      • 21.3.10.4. SWOT Analysis
      • 21.3.10.5. Key Developments
      • 21.3.10.6. Sales Footprint
      • 21.3.10.7. Strategy Overview
        • 21.3.10.7.1. Marketing Strategy
        • 21.3.10.7.2. Product Strategy
        • 21.3.10.7.3. Channel Strategy
    • 21.3.11. Sigma-Aldrich
      • 21.3.11.1. Overview
      • 21.3.11.2. Product & Services Portfolio
      • 21.3.11.3. Key Financials
      • 21.3.11.4. SWOT Analysis
      • 21.3.11.5. Key Developments
      • 21.3.11.6. Sales Footprint
      • 21.3.11.7. Strategy Overview
        • 21.3.11.7.1. Marketing Strategy
        • 21.3.11.7.2. Product Strategy
        • 21.3.11.7.3. Channel Strategy
    • 21.3.12. Takara Bio Inc
      • 21.3.12.1. Overview
      • 21.3.12.2. Product & Services Portfolio
      • 21.3.12.3. Key Financials
      • 21.3.12.4. SWOT Analysis
      • 21.3.12.5. Key Developments
      • 21.3.12.6. Sales Footprint
      • 21.3.12.7. Strategy Overview
        • 21.3.12.7.1. Marketing Strategy
        • 21.3.12.7.2. Product Strategy
        • 21.3.12.7.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology